Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shiwei Anshen granules
- Development stage
- Preclinical
- Lead developer
- Hebei Ping An Health Group
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Shiwei Anshen granules (十味安神颗粒) is a Traditional Chinese Medicine (TCM) herbal preparation developed by Dongzhimen Hospital of Beijing University of Chinese Medicine and Hebei Pingan Health Group for the treatment of chronic insomnia. The formulation is derived from a clinical experience prescription of Shijiazhuang Pingan Hospital and is composed of ten herbal ingredients, including Fructus Corni (山茱萸), Rhizoma Anemarrhenae (知母), Fructus Schisandrae (五味子), and Semen Ziziphi Spinosae (酸枣仁). It is designed to nourish liver and kidney yin, clear heat, purge fire, and restore harmony between the heart and kidney (addressing Yin-Deficiency Fire-Hyperactivity and Heart-Kidney Disharmony Syndrome). In April 2026, Hebei Pingan Health Group, with IND technical support from Beijing Yingkerui, received clinical trial approval from the National Medical Products Administration (NMPA) for Shiwei Anshen granules as a Class 1.1 innovative TCM drug.
- Other names
- Shiwei Anshen GranulesShiwei-Anshen十味安神颗粒
Beyond the preview
Go deeper on Shiwei Anshen granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shiwei Anshen granules.